Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00970736
Other study ID # C6697-M
Secondary ID
Status Completed
Phase N/A
First received September 1, 2009
Last updated March 5, 2015
Start date November 2009
Est. completion date October 2011

Study information

Verified date December 2014
Source VA Office of Research and Development
Contact n/a
Is FDA regulated No
Health authority United States: Federal Government
Study type Observational

Clinical Trial Summary

The goal of this project is to examine the area of the brain that controls muscle movement for a group of muscles important for swallowing, and to see how that area changes over 2 weeks of time.


Description:

A large number of our nation's veterans develop dysphagia due to the myriad of potential etiological sources of swallowing disorders, including stroke and head and neck cancer. The Veteran's Health Administration has recently identified dysphagia as a major clinical focus for the VA system (Sullivan & Dennis, 2006). In order to accurately assess adaptations in motor cortex, it is first necessary to have a reliable tool for measuring organizational representation in the motor cortex. Transcranial magnetic stimulation (TMS) is a desirable choice for such measurement because of the ability to identify causative relationships between an area of motor cortex stimulated and muscle response. Therefore, the specific research objectives of this proposal are:

1. To demonstrate the reproducibility of TMS mapping of the submental muscle group in healthy older adults between 60 and 80 years of age

2. To determine the neural representation of submental musculature in the motor cortex of healthy older adults between 60 and 80 years of age.

Twenty healthy adults, 10 men and 10 women, between the ages of 60 and 80 years will serve as research participants. TMS will be used to establish motor maps of the submental muscles. Subjects will undergo two testing sessions, on day 1 and day 14. The results from each session will be compared to assess excitability and representation within the motor cortex, and to assess stability and reliability of measurement.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date October 2011
Est. primary completion date October 2011
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 60 Years to 80 Years
Eligibility Inclusion Criteria:

- Between 60 and 80 years of age

Exclusion Criteria:

- History of dysphagia

- History of neurologic disease

- History of head or neck cancer

- History of stroke

- Untreated hypertension

- History of a heart condition or heart disease

- Currently pregnant

- Contraindication to TMS including:

- Metallic hardware on the scalp in the area where TMS will be applied

- Cardiac pacemaker

- Implanted medication pumps or an intracardiac line

- Prior diagnosis of seizure or epilepsy in the subject (childhood history of benign febrile seizure will not be a contraindication)

- Poorly controlled migraine headaches

- Previous brain neurosurgery

- Medications that can lower seizure threshold (Appendix B)

- Unstable medical conditions

- Lowest motor thresholds above 80% on TMS

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
United States North Florida/South Georgia Veterans Health System Gainesville Florida

Sponsors (1)

Lead Sponsor Collaborator
VA Office of Research and Development

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Mean Motor Evoked Potential Amplitude for Submental Cortical Representation Cortical sites are stimulated sequentially from the SOLMT in the anterior direction. At each site, 5 pulses of 110% of the MEP threshold obtained at the SOLMT are delivered and recorded. If a site produces no MEP in 3/5 pulses it is considered non-submental. This process is continued until the entire submental representation is surrounded by non-submental responsive sites. The number of sites is used to calculate the area of submental representation. The mean sEMG amplitudes of the submental muscles for each of these sites is then calculated for the mean MEP measure. 2 weeks No
Secondary Motor Map Center of Gravity Position on the TMS motor map with highest amplitude response to stimulation in the muscles of interest (submental muscles). 2 weeks No
Secondary Area of Submental Representation Cortical sites are stimulated sequentially from the SOLMT in the anterior direction. At each site, 5 pulses of 110% of the MEP threshold obtained at the SOLMT are delivered and recorded. If a site produces no MEP in 3/5 pulses it is considered non-submental. This process is continued until the entire submental representation is surrounded by non-submental responsive sites. The number of sites is used to calculate the area of submental representation. 2 weeks No
See also
  Status Clinical Trial Phase
Withdrawn NCT01184027 - Impact of Nutrition and Swallowing Function of Head and Neck Cancer Patients During the Course of Treatment N/A
Completed NCT04671277 - Oral Processing Behavior of Gluten-free and Gluten-containing Breads N/A
Recruiting NCT01065961 - Randomized Controlled Trials of the Effects of Decadron on Swallowing, Airway, and Arthrodesis Phase 1/Phase 2
Completed NCT01519388 - Evaluation of the Impact on Swallowing of Non Invasive Ventilation N/A